Molecular Mechanisms of Inflammation: Induction, Resolution and Escape by Helicobacter Pylori (Hardcover, 2019)

1. Nina Salama (Seattle, Washington, USA): Inflammation, immunity and vaccine development for the gastric pathogen Helicobacter pylori.- 2. Jay Solnick (Davis, California, USA): Impact of Helicobacter pylori virulence factors on the host immune system and development of gastric pathologies.- 3. Michael Naumann (Magdeburg, Germany): Crosstalk between DNA damage and inflammation in the multiple steps of gastric carcinogenesis.- 4. Emad El-Omar (Sydney, Australia): Genetic polymorphisms in inflammatory regulators control the prognosis of gastric cancer development.- 5. Richard Peek (Nashville, Tennessee, USA): Helicobacter pylori infection, inflammation and gastric carcinogenesis in animal models and gastroids.- 6. Georgina Hold (Sydney, Australia) or Martin Blaser (New York, USA): Impact of the gastrointestinal microbiome in health and disease: co-evolution with the host immune system.- 7. Yoshio Yamaoka (Oita, Japan): Importance of toll-like receptors in pro-inflammatory and anti-inflammatory responses by Helicobacter pylori.- 8. Richard Ferrero (Melbourne, Australia): Role of TIFA and Nod1 signaling in innate immunity against Helicobacter pylori infection.- 9. Sarah Linden (Gothenburg, Sweden): Carbohydrate-dependent and antimicrobial peptide defense mechanisms against Helicobacter pylori infection.- 10. Thomas Meyer (Berlin, Germany): Depletion of cholesterol by Helicobacter pylori prevents IFN signaling and escape of inflammatory responses.- 11. Anne Muller (Zurich, Switzerland): Helicobacter pylori deregulates T and B cell signaling to trigger immune evasion and development of MALT lymphoma.- 12. Steffen Backert (Erlangen, Germany): Mechanisms of inflammasome signaling, micro RNA induction, cytokine dynamics and resolution of inflammation by Helicobacter pylori.- 13. Yongsheng Li (Chongqing , China): Resolution of cancer-promoting inflammation: a novel strategy for anti-cancer therapy.